查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1948399

2026年全球子宮肌瘤栓塞器械市場報告

Uterine Fibroid Embolization Device Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，子宮肌瘤栓塞器械的市場規模持續擴大，預計將從2025年的59.3億美元成長到2026年的61.9億美元，複合年成長率（CAGR）為4.4%。過去幾年的成長可歸因於以下因素：育齡婦女子宮肌瘤患病率的上升、醫院和診所婦科手術數量的增加、介入放射學中子宮動脈栓塞術的日益普及、人們對開放式肌瘤切除術之外的替代治療方法的認知不斷提高，以及三級醫療機構微創治療流程的擴展。

預計未來幾年子宮肌瘤栓塞器械市場將穩定成長，到2030年市場規模將達到73.3億美元，複合年成長率（CAGR）為4.3%。預測期內的成長要素包括：年輕患者對保留子宮的子宮肌瘤治療需求不斷成長；臨床治療模式向微創和非侵入性治療模式的轉變日益明顯；門診手術中心手術普及率不斷提高；消融和栓塞器械在縮小肌瘤方面的應用日益廣泛；以及為提高治療精準度而加大對先進導管輸送和栓塞系統的投資。預測期內的主要趨勢包括：微創栓塞技術在子宮肌瘤治療中的應用日益普及；臨床上越來越傾向於選擇保留器官的治療方案而非子宮切除術；影像引導介入器械在靶向肌瘤治療中的應用日益廣泛；栓塞術在門診和日間手術中的廣泛應用；以及對精準輸送系統以提高手術安全性和療效的需求不斷成長。

微創手術需求的不斷成長預計將推動子宮肌瘤栓塞器械市場的成長。微創手術是指透過微小切口或自然腔道進入並治療器官、組織和結構，同時最大限度地減少患者不適的手術。隨著越來越多的患者和醫療機構尋求更短的恢復時間、更低的併發症風險和更高的整體舒適度，此類手術的需求也不斷成長。子宮肌瘤栓塞器械透過達到肌瘤的精準有效治療，改善患者預後並提高手術效率，進而為這些手術提供支持。例如，根據美國醫學期刊《AOS Open》的報告，截至2025年1月，在採用機器人輔助系統的醫院中，微創手術佔所有手術的65.8%，高於2022年的60.5%。因此，對微創手術日益成長的需求正在推動子宮肌瘤栓塞器械市場的發展。

該市場中的企業正致力於研發創新技術，例如微創子宮肌瘤管理軟體，以提高子宮肌瘤治療的精準度和效率。這類軟體為臨床醫師提供先進的數位化工具，輔助其規劃、指導和實施微創手術，進而提高手術的準確性、安全性和病患療效。例如，2024年9月，專注於微創婦科手術的美國醫療設備製造商Gynesonics發布了適用於其Sonata系統的SMART OS 2.4軟體。軟體將最小消融區域尺寸從2.0 x 1.3厘米縮小至1.6 x 1.2厘米，消融體積減少了38%，並最佳化了較小子宮肌瘤的熱感安全邊界。這使得治療過程更加可控，同時也最大限度地保護了健康的子宮組織。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球子宮肌瘤栓塞器械市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧（AI）和自主人工智慧
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 微創栓塞術在治療子宮肌瘤的應用日益廣泛
    • 臨床上越來越傾向選擇保留器官而非子宮切除術的替代方案
    • 擴大影像導引介入設備在子宮肌瘤標靶治療的應用
    • 擴大栓塞術在門診和日間手術的應用
    • 為提高手術安全性和治療效果，對精準輸送系統的需求日益成長

第5章 終端用戶產業市場分析

  • 醫院
  • 診所
  • 門診手術中心
  • 專業婦科中心
  • 其他

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球子宮肌瘤栓塞器械市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球子宮肌瘤栓塞器械市場規模、對比及成長率分析
  • 全球子宮肌瘤栓塞器械市場表現：規模與成長，2020-2025年
  • 全球子宮肌瘤栓塞器械市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場總量（TAM）

第9章 市場細分

  • 透過技術
  • 外科手術、腹腔鏡手術、消融治療、栓塞術
  • 透過治療方法
  • 侵入性治療，微創治療
  • 最終用戶
  • 醫院、診所及門診手術中心
  • 按類型細分：手術治療方法
  • 開放性手術，子宮肌瘤切除術
  • 依類型細分：腹腔鏡手術技術
  • 腹腔鏡子宮肌瘤切除術，腹腔鏡子宮切除術
  • 按類型細分：消融技術
  • 射頻消融、微波消融、冷凍消融
  • 依類型細分：栓塞
  • 經導管動脈栓塞術（TAE）、子宮動脈栓塞術（UAE）

第10章 區域與國家分析

  • 全球子宮肌瘤栓塞器械市場：區域分析、預測（2020-2025年、2025-2030年預測、2035年預測）
  • 全球子宮肌瘤栓塞器械市場：國家、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 子宮肌瘤栓塞器械市場：競爭格局及市佔率（2024年）
  • 子宮肌瘤栓塞器械市場：公司估值矩陣
  • 子宮肌瘤栓塞器械市場：公司概況
    • Johnson and Johnson Pvt Ltd.
    • Medtronic plc.
    • Boston Scientific Corporation
    • Olympus Corporation
    • Terumo Corporation

第37章：其他領先和創新企業

  • Ethicon Inc., Hologic Inc., CooperSurgical Inc., Cook Medical Inc., Karl Storz GmbH, Merit Medical Systems, CONMED Corporation, Lumenis Ltd., Richard Wolf GmbH, BTG International Ltd., Healthium MedTech Pvt. Ltd., Hironic Co.Ltd, Minerva Surgical Inc., Gynesonics Inc., Advanced Surgical Concepts PLLC

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年子宮肌瘤栓塞器械市場：提供新機會的國家
  • 2030年子宮肌瘤栓塞器械市場：充滿新機會的細分市場
  • 2030年子宮肌瘤栓塞器械市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME3MUFED01_G26Q1

A uterine fibroid embolization device is a medical device used in the treatment of noncancerous tumors, specifically uterine fibroids, through a minimally invasive procedure. Uterine fibroids are benign growths in the uterus, and this device functions by restricting the blood supply to these fibroids, causing them to shrink and ultimately disappear.

The main types of technologies associated with uterine fibroid embolization devices include surgical techniques, laparoscopic techniques, ablation techniques, and embolization techniques. Surgical techniques involve specific methods and procedures employed by medical professionals. These devices are utilized in various treatment modes, including invasive, minimally invasive, and non-invasive treatments. Additionally, they find application in diverse healthcare settings such as hospitals, clinics, and ambulatory surgical centers.

Tariffs are impacting the uterine fibroid embolization device market by increasing the import and manufacturing costs of embolic agents, microcatheters, delivery systems, and imaging-guided interventional components, leading to higher procedure costs across hospitals, clinics, and ambulatory surgical centers. The effect is more pronounced in regions relying on cross-border sourcing of interventional radiology devices, particularly in North America, Europe, and Asia-Pacific specialty care markets. Segments such as embolization techniques and minimally invasive treatment systems experience the strongest pricing pressure; however, tariffs are also encouraging domestic assembly, regional supply localization, and innovation in cost-efficient device design, which supports long-term supply resilience and market competitiveness.

The uterine fibroid embolization device market research report is one of a series of new reports from The Business Research Company that provides uterine fibroid embolization device market statistics, including uterine fibroid embolization device industry global market size, regional shares, competitors with a uterine fibroid embolization device market share, detailed uterine fibroid embolization device market segments, market trends and opportunities, and any further data you may need to thrive in the uterine fibroid embolization device industry. This uterine fibroid embolization device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The uterine fibroid embolization device market size has grown steadily in recent years. It will grow from $5.93 billion in 2025 to $6.19 billion in 2026 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to rising prevalence of uterine fibroids among women of reproductive age, growing number of hospital and clinic-based gynecological procedures, increasing adoption of uterine artery embolization in interventional radiology, greater awareness of alternatives to open surgical myomectomy, expansion of minimally invasive treatment workflows in tertiary care centers.

The uterine fibroid embolization device market size is expected to see steady growth in the next few years. It will grow to $7.33 billion in 2030 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to rising demand for uterus-sparing fibroid treatments in younger patient populations, growing clinical shift toward minimally invasive and non-invasive treatment modes, increasing procedural penetration in ambulatory surgical centers, expanding use of ablation and embolization devices for fibroid size reduction, rising investments in advanced delivery catheters and embolic systems to improve treatment precision. Major trends in the forecast period include rising adoption of minimally invasive embolization techniques for uterine fibroid treatment, increasing clinical preference for organ-preserving alternatives to hysterectomy, growing utilization of image-guided interventional devices for targeted fibroid therapy, expanding use of embolization procedures in outpatient and ambulatory surgical settings, increasing demand for precision delivery systems to improve procedural safety and outcomes.

The growing demand for minimally invasive surgeries is expected to drive the growth of the uterine fibroid embolization device market. Minimally invasive surgeries involve small incisions or the use of natural body openings to access and treat internal organs, tissues, or structures while minimizing trauma to the patient. The demand for these procedures is increasing as patients and healthcare providers seek treatments that reduce recovery time, lower complication risks, and improve overall comfort. Uterine fibroid embolization devices facilitate these procedures by enabling precise and effective treatment of fibroids, improving patient outcomes and procedural efficiency. For instance, in January 2025, according to AOS Open, a US-based medical journal, hospitals with robotic-assisted systems reported that minimally invasive surgeries accounted for 65.8% of procedures in 2025, up from 60.5% in 2022. Therefore, the growing demand for minimally invasive surgeries is propelling the uterine fibroid embolization device market.

Companies in this market are focusing on innovations such as minimally invasive fibroid management software to improve precision and efficiency in uterine fibroid treatment. This type of software provides clinicians with advanced digital tools to plan, guide, and execute minimally invasive procedures, enhancing procedural accuracy, safety, and patient outcomes. For example, in September 2024, Gynesonics, a US-based medical device company specializing in minimally invasive gynecologic treatments, launched SMART OS 2.4 software for the Sonata System. The software reduces the minimum ablation zone size from 2.0 X 1.3 cm to 1.6 X 1.2 cm, decreases ablation volume by 38%, and optimizes the Thermal Safety Border for smaller fibroids, enabling more controlled treatments while preserving healthy uterine tissue.

In October 2024, Hologic Inc., a US-based medical technology company, acquired Gynesonics for $350 million. This acquisition expands Hologic's portfolio of minimally invasive treatment options for women's health, particularly in the management of uterine fibroids and heavy menstrual bleeding. Gynesonics develops minimally invasive solutions for the treatment of symptomatic uterine fibroids, and its integration strengthens Hologic's position in the women's health market.

Major companies operating in the uterine fibroid embolization device market are Johnson and Johnson Pvt Ltd., Medtronic plc., Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Ethicon Inc., Hologic Inc., CooperSurgical Inc., Cook Medical Inc., Karl Storz GmbH, Merit Medical Systems, CONMED Corporation, Lumenis Ltd., Richard Wolf GmbH, BTG International Ltd., Healthium MedTech Pvt. Ltd., Hironic Co.Ltd, Minerva Surgical Inc., Gynesonics Inc., Advanced Surgical Concepts PLLC

North America was the largest region in the uterine fibroid embolization device market in 2025. The regions covered in the uterine fibroid embolization device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the uterine fibroid embolization device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The uterine fibroid embolization device market consists of revenues earned by entities by provide services such as minimally invasive procedures, non-invasive procedures, minimally invasive procedures, radiofrequency ablation, medication and hormonal therapy, and embolization procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The uterine fibroid embolization device market also includes sales of medications, hysteroscopic devices, laparoscopic devices, radiofrequency ablation devices, endometrial ablation devices, hysterectomy devices, and robotic surgical systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Uterine Fibroid Embolization Device Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses uterine fibroid embolization device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for uterine fibroid embolization device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The uterine fibroid embolization device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Technology: Surgical Techniques; Laparoscopic Techniques; Ablation Techniques; Embolization Techniques
  • 2) By Mode Of Treatment: Invasive Treatment; Minimally Invasive Treatment
  • 3) By End User: Hospitals; Clinics; Ambulatory Surgical Center
  • Subsegments:
  • 1) By Surgical Techniques: Open Surgery; Myomectomy
  • 2) By Laparoscopic Techniques: Laparoscopic Myomectomy; Laparoscopic Hysterectomy
  • 3) By Ablation Techniques: Radiofrequency Ablation; Microwave Ablation; Cryoablation
  • 4) By Embolization Techniques: Transcatheter Arterial Embolization (TAE); Uterine Artery Embolization (UAE)
  • Companies Mentioned: Johnson and Johnson Pvt Ltd.; Medtronic plc.; Boston Scientific Corporation; Olympus Corporation; Terumo Corporation; Ethicon Inc.; Hologic Inc.; CooperSurgical Inc.; Cook Medical Inc.; Karl Storz GmbH; Merit Medical Systems; CONMED Corporation; Lumenis Ltd.; Richard Wolf GmbH; BTG International Ltd.; Healthium MedTech Pvt. Ltd.; Hironic Co.Ltd; Minerva Surgical Inc.; Gynesonics Inc.; Advanced Surgical Concepts PLLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Uterine Fibroid Embolization Device Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Uterine Fibroid Embolization Device Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Uterine Fibroid Embolization Device Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Uterine Fibroid Embolization Device Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Minimally Invasive Embolization Techniques For Uterine Fibroid Treatment
    • 4.2.2 Increasing Clinical Preference For Organ-Preserving Alternatives To Hysterectomy
    • 4.2.3 Growing Utilization Of Image-Guided Interventional Devices For Targeted Fibroid Therapy
    • 4.2.4 Expanding Use Of Embolization Procedures In Outpatient And Ambulatory Surgical Settings
    • 4.2.5 Increasing Demand For Precision Delivery Systems To Improve Procedural Safety And Outcomes

5. Uterine Fibroid Embolization Device Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Ambulatory Surgical Centers
  • 5.4 Specialty Gynecology Centers
  • 5.5 Others

6. Uterine Fibroid Embolization Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Uterine Fibroid Embolization Device Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Uterine Fibroid Embolization Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Uterine Fibroid Embolization Device Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Uterine Fibroid Embolization Device Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Uterine Fibroid Embolization Device Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Uterine Fibroid Embolization Device Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Uterine Fibroid Embolization Device Market Segmentation

  • 9.1. Global Uterine Fibroid Embolization Device Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Surgical Techniques, Laparoscopic Techniques, Ablation Techniques, Embolization Techniques
  • 9.2. Global Uterine Fibroid Embolization Device Market, Segmentation By Mode Of Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Invasive Treatment, Minimally Invasive Treatment
  • 9.3. Global Uterine Fibroid Embolization Device Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinics, Ambulatory Surgical Center
  • 9.4. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Surgical Techniques, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Open Surgery, Myomectomy
  • 9.5. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Laparoscopic Techniques, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Laparoscopic Myomectomy, Laparoscopic Hysterectomy
  • 9.6. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Ablation Techniques, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Radiofrequency Ablation, Microwave Ablation, Cryoablation
  • 9.7. Global Uterine Fibroid Embolization Device Market, Sub-Segmentation Of Embolization Techniques, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Transcatheter Arterial Embolization (TAE), Uterine Artery Embolization (UAE)

10. Uterine Fibroid Embolization Device Market Regional And Country Analysis

  • 10.1. Global Uterine Fibroid Embolization Device Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Uterine Fibroid Embolization Device Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Uterine Fibroid Embolization Device Market

  • 11.1. Asia-Pacific Uterine Fibroid Embolization Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Uterine Fibroid Embolization Device Market

  • 12.1. China Uterine Fibroid Embolization Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Uterine Fibroid Embolization Device Market

  • 13.1. India Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Uterine Fibroid Embolization Device Market

  • 14.1. Japan Uterine Fibroid Embolization Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Uterine Fibroid Embolization Device Market

  • 15.1. Australia Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Uterine Fibroid Embolization Device Market

  • 16.1. Indonesia Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Uterine Fibroid Embolization Device Market

  • 17.1. South Korea Uterine Fibroid Embolization Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Uterine Fibroid Embolization Device Market

  • 18.1. Taiwan Uterine Fibroid Embolization Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Uterine Fibroid Embolization Device Market

  • 19.1. South East Asia Uterine Fibroid Embolization Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Uterine Fibroid Embolization Device Market

  • 20.1. Western Europe Uterine Fibroid Embolization Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Uterine Fibroid Embolization Device Market

  • 21.1. UK Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Uterine Fibroid Embolization Device Market

  • 22.1. Germany Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Uterine Fibroid Embolization Device Market

  • 23.1. France Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Uterine Fibroid Embolization Device Market

  • 24.1. Italy Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Uterine Fibroid Embolization Device Market

  • 25.1. Spain Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Uterine Fibroid Embolization Device Market

  • 26.1. Eastern Europe Uterine Fibroid Embolization Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Uterine Fibroid Embolization Device Market

  • 27.1. Russia Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Uterine Fibroid Embolization Device Market

  • 28.1. North America Uterine Fibroid Embolization Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Uterine Fibroid Embolization Device Market

  • 29.1. USA Uterine Fibroid Embolization Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Uterine Fibroid Embolization Device Market

  • 30.1. Canada Uterine Fibroid Embolization Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Uterine Fibroid Embolization Device Market

  • 31.1. South America Uterine Fibroid Embolization Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Uterine Fibroid Embolization Device Market

  • 32.1. Brazil Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Uterine Fibroid Embolization Device Market

  • 33.1. Middle East Uterine Fibroid Embolization Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Uterine Fibroid Embolization Device Market

  • 34.1. Africa Uterine Fibroid Embolization Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Uterine Fibroid Embolization Device Market, Segmentation By Technology, Segmentation By Mode Of Treatment, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Uterine Fibroid Embolization Device Market Regulatory and Investment Landscape

36. Uterine Fibroid Embolization Device Market Competitive Landscape And Company Profiles

  • 36.1. Uterine Fibroid Embolization Device Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Uterine Fibroid Embolization Device Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Uterine Fibroid Embolization Device Market Company Profiles
    • 36.3.1. Johnson and Johnson Pvt Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Olympus Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Uterine Fibroid Embolization Device Market Other Major And Innovative Companies

  • Ethicon Inc., Hologic Inc., CooperSurgical Inc., Cook Medical Inc., Karl Storz GmbH, Merit Medical Systems, CONMED Corporation, Lumenis Ltd., Richard Wolf GmbH, BTG International Ltd., Healthium MedTech Pvt. Ltd., Hironic Co.Ltd, Minerva Surgical Inc., Gynesonics Inc., Advanced Surgical Concepts PLLC

38. Global Uterine Fibroid Embolization Device Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Uterine Fibroid Embolization Device Market

40. Uterine Fibroid Embolization Device Market High Potential Countries, Segments and Strategies

  • 40.1 Uterine Fibroid Embolization Device Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Uterine Fibroid Embolization Device Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Uterine Fibroid Embolization Device Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer